Real-time enrollment status for this hcc clinical trial
Current Status
Recruiting
Checked: August 19, 2026 at 6:56 PM UTC
| NCT Number | NCT07722741 |
| Recruiting Status | Recruiting |
| Condition | HCC |
| Phase | PHASE2 |
| Target Enrollment | 90 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Geneos Therapeutics |
| Last Updated on CT.gov | August 18, 2026 (Yesterday) |
As of August 19, 2026: Clinical trial NCT07722741 is currently recruiting participants. This phase2 study for hcc is actively seeking new participants at 7 locations across the United States. The study is sponsored by Geneos Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07722741 is actively recruiting participants as of August 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07722741 was last updated Yesterday (August 18, 2026). HelloStudys verifies this status automatically.